The CDC, which calls the fungus “a serious global health threat,” reported that in 2019, 66 newly confirmed and probable cases of C. auris have emerged across the country. At the end of 2018, there were 551 confirmed and probable C. auris in the U.S.
C. auris is a type of yeast that can cause bloodstream, wound and ear infections. It is resistant to commonly used antifungal medications. C. auris spreads in healthcare settings in many ways, including through contact with contaminated environmental surfaces or equipment and from person to person.
The following three states have seen the highest number of C. auris cases as of Feb. 28:
● New York: 309
● Illinois: 144
● New Jersey: 104
C. auris cases have been reported among hospitalized patients around the world, including Australia, Canada, China, Colombia, France, Germany, India and Israel, among others.
The first seven cases of C. auris were reported in the U.S. in 2016, USA Today reports. In addition to the 617 confirmed and probably C. auris cases in the country, 1,056 patients were colonized with C. auris but did not show any symptoms.
More articles on healthcare quality:
New Jersey nurse staffing improved after public disclosure law enacted, study finds
CDC’s secrecy of drug-resistant outbreaks in hospitals sparks patient safety debate
78 measles cases reported in 1 week, says CDC
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.